SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150 | -56.3% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $343 | -99.8% | 7,300 | +55.3% | 0.00% | 0.0% |
| Q3 2022 | $184,000 | -27.8% | 4,700 | -40.5% | 0.00% | 0.0% |
| Q2 2022 | $255,000 | -80.5% | 7,900 | -65.8% | 0.00% | -80.0% |
| Q2 2021 | $1,311,000 | +58.7% | 23,093 | +109.1% | 0.01% | +66.7% |
| Q1 2021 | $826,000 | -78.0% | 11,043 | -78.8% | 0.00% | -81.2% |
| Q4 2019 | $3,753,000 | -83.2% | 52,000 | -67.4% | 0.02% | -67.3% |
| Q3 2019 | $22,344,000 | -0.4% | 159,284 | +30.0% | 0.05% | -51.0% |
| Q2 2019 | $22,436,000 | -29.3% | 122,543 | -38.6% | 0.10% | -30.6% |
| Q1 2019 | $31,730,000 | +44.0% | 199,500 | -13.3% | 0.14% | +28.6% |
| Q4 2018 | $22,031,000 | +9.5% | 230,000 | +61.5% | 0.11% | +27.3% |
| Q3 2018 | $20,116,000 | +505.9% | 142,417 | +571.4% | 0.09% | +528.6% |
| Q2 2018 | $3,320,000 | -32.4% | 21,211 | -30.5% | 0.01% | -36.4% |
| Q1 2018 | $4,912,000 | +4.3% | 30,500 | +6.6% | 0.02% | +10.0% |
| Q4 2017 | $4,710,000 | +8.2% | 28,600 | -59.1% | 0.02% | +5.3% |
| Q3 2017 | $4,354,000 | +0.7% | 69,900 | +28.7% | 0.02% | 0.0% |
| Q2 2017 | $4,324,000 | -41.3% | 54,300 | -47.6% | 0.02% | -40.6% |
| Q1 2017 | $7,362,000 | +39.5% | 103,600 | +0.2% | 0.03% | +39.1% |
| Q4 2016 | $5,279,000 | +17.6% | 103,400 | +6.1% | 0.02% | +15.0% |
| Q3 2016 | $4,489,000 | +1794.1% | 97,500 | +1217.6% | 0.02% | +1900.0% |
| Q1 2016 | $237,000 | -68.7% | 7,400 | -43.1% | 0.00% | -66.7% |
| Q4 2015 | $757,000 | +37.6% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $550,000 | -42.0% | 13,000 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $949,000 | – | 13,000 | – | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2014 | $73,000 | -42.1% | 2,000 | -50.0% | 0.00% | – |
| Q3 2014 | $126,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |